+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

iVascular SLU - Product Pipeline Analysis, 2019 Update

  • PDF Icon

    Company Profile

  • 22 Pages
  • January 2020
  • GlobalData
  • ID: 4455811

iVascular SLU (iVascular) is a designer and developer of advanced medical devices and implants for the treatment of cardiovascular system disorders. The company offers products in the fields of interventional cardiology, endovascular intervention and interventional neuroradiology including drug eluting balloons, drug eluting stents, self-expandable stents, and thrombus extraction catheters, among others. It develops its product based on its proprietary technologies such as laser cutting, and drug coating. iVascular is headquartered in Barcelona, Spain.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company iVascular SLU
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

  • iVascular SLU Company Overview
  • iVascular SLU Company Snapshot
  • iVascular SLU Pipeline Products and Ongoing Clinical Trials Overview
  • iVascular SLU – Pipeline Analysis Overview
  • iVascular SLU - Key Facts
  • iVascular SLU - Major Products and Services
  • iVascular SLU Pipeline Products by Development Stage
  • iVascular SLU Pipeline Products Overview
  • Interventional Neuroradiology - Catheter
  • Interventional Neuroradiology - Catheter Product Overview
  • Scoring Balloon
  • Scoring Balloon Product Overview
  • Sergeant Support Catheter
  • Sergeant Support Catheter Product Overview
  • iVascular SLU - Key Competitors
  • iVascular SLU - Locations And Subsidiaries
  • Head Office
  • Recent Developments
  • iVascular SLU, Recent Developments
  • May 08, 2019: EFFPAC 2-year safety and efficacy outcomes presented at EuroPcr
  • Dec 05, 2017: iVascular starts partnership with TD Medical
  • Dec 04, 2017: Oceanus 14 Pro, PTA balloon catheter receives CE Mark Approval
  • Sep 25, 2017: The T.I.N.T.I.N. trial evaluating the combined therapy of Luminor DCB and iVolution SX stent
  • Sep 21, 2017: Luminor 14m has received the Canadian Medical Device License
  • Sep 18, 2017: iVascular EffPAC 6 Months Outstanding Data Presented at CIRSE 2017 DCB Session
  • Jul 25, 2017: Angiolite BTK, below the knee sirolimus-eluting stent, receives CE Mark Approval
  • Apr 03, 2017: iVascular Receives CE Mark Approval for iVolution 200mm SX stent
  • Mar 20, 2017: Capturer 7F has just received CE mark
  • Feb 20, 2017: LUMINOR Registry may help “reopen the door” for drug-coated balloons below the knee
  • Appendix
  • Methodology
  • About the Author
  • Contact Us
  • Disclaimer

List of Tables
  • iVascular SLU Pipeline Products and Ongoing Clinical Trials Overview
  • iVascular SLU Pipeline Products by Equipment Type
  • iVascular SLU Pipeline Products by Indication
  • iVascular SLU, Key Facts
  • iVascular SLU, Major Products and Services
  • iVascular SLU Number of Pipeline Products by Development Stage
  • iVascular SLU Pipeline Products Summary by Development Stage
  • Interventional Neuroradiology - Catheter - Product Status
  • Interventional Neuroradiology - Catheter - Product Description
  • Scoring Balloon - Product Status
  • Scoring Balloon - Product Description
  • Sergeant Support Catheter - Product Status
  • Sergeant Support Catheter - Product Description
  • Glossary

List of Figures
  • iVascular SLU Pipeline Products by Equipment Type
  • iVascular SLU Pipeline Products by Development Stage



Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Sylentis, S.A.
  • Laboratorios Inibsa SA
  • Iberhospitex SA
  • GHX Europe